
Get free access to all the Money Morning stock ratings right now to find out which stocks scored at the top of our list. Just enter your email address:
By submitting your email address you will receive a free subscription to Money Morning and occasional special offers from Money Map Press and our affiliates. You can unsubscribe at anytime and we encourage you to read more about our privacy policy.
Latest Updates on GILD
-
Dow Jones The Dow Jones Today Could Surge If Shutdown Agreement Passes
By Garrett Baldwin, Economist, Money Morning •
The Dow Jones today is projecting a 210-point gain on news that U.S. lawmakers have drafted an agreement that could prevent another government shutdown from coming this week. While that's great news for stocks, an agreement with China … Read more » -
Dow Jones Dow Jones Industrial Average Attempts Rebound as October Volatility Accelerates
By Garrett Baldwin, Economist, Money Morning •
The Dow Jones Industrial Average turned negative for the year after Wednesday's 608-point selloff. This morning, the Dow projected a 136-point gain as the October's market rollercoaster continued. Read more » -
Biotechnology This Baby Biotech Has Lots of Running Room, Thanks to This Upcoming "Super" Drug
By William Patalon III, Executive Editor, Money Morning • @privatebrief •
Our Bill Patalon first introduced this biotech company to you on the very first day he published his Private Briefing service, and it's been a huge winner for you since. Read more » -
Trading Strategies How to Trade a Market at Record Levels (and the One Company Poised to Play "Catch Up")
This expert insight from Keith Fitz-Gerald originally ran in Total Wealth on
Killer profits are the backbone of investing. Creating them feels good and can have a powerful impact on your life. Surprisingly, this isn't difficult. Contrary to what most investors believe, you don't have to have a hot tip … Read more » -
Dow Jones Dow Jones Today Falls 80 Points as Fed FOMC Meeting Looms
By Garrett Baldwin, Economist, Money Morning •
The Dow Jones today traded 80 points lower in pre-market trading as the Federal Reserve kicked off its quarterly Federal Open Market Committee meeting. Markets anticipate that the Fed will hold off on raising interest rates until June. … Read more » -
Biotech Why Mark Cuban Invested in This 22-Year-Old Entrepreneur's Biotech Business
By A.J. Bursick, Associate Editor, Money Morning •
Billionaire entrepreneur Mark Cuban invested in a small biotech company that will revolutionize the way doctors approach chest pains. Of course, average investors don't have the ability to invest in such companies pre-IPO. Read more » -
Biotechnology My Top Biotech Play for 2018 Could Make You 110.5% in 12 Months, If You Act Now
This expert insight from Michael A. Robinson originally ran in Strategic Tech Investor on
Between Oct. 5 and Nov. 11, one of the bellwether biotech exchange-traded funds fell 10.5%. That's a correction, as defined by most market watchers. And most investors - and their "enablers" on Wall Street - have shied away from … Read more » -
Dow Jones How a Crisis in Europe Is Sinking the Dow Jones Today
By Garrett Baldwin, Economist, Money Morning •
The Dow Jones today is dropping thanks to more turmoil in Spain over Catalonian secession... Dow Jones futures are down 85 points ahead of the opening bell as Spain's proposal to strip Catalonia's leaders of their authority tanked European … Read more » -
Stocks Ford, Aerojet Rocketdyne, and Gilead Sciences Are Stocks to Watch Now
By Stephen Mack, Associate Editor, Money Morning •
Our latest list of stocks to watch now includes an auto company with a super luxury truck, an aerospace contractor honored by NASA, and a pharmaceutical company getting attention from Wall Street. Read more » -
Stocks Stocks to Watch Now: JinkoSolar, SoftBank, Gilead Sciences
By Stephen Mack, Associate Editor, Money Morning •
Here's a look at three new stocks to watch. A solar energy stock may be flying too close to the sun, a massive new private equity fund gets its feet wet, and a fallen biotech star may be ready for another breakout. Read more » -
Biotechnology Three Biotech Bargains to Buy Right Now
This expert insight from Michael A. Robinson originally ran in Strategic Tech Investor on
Back in October, I did something crazy. That's when I told the paid-up members of my Radical Technology Profits trading service to buy a small-cap biotech stock. Here's why that move was a bit … Read more » -
Dow Jones Dow Jones News Today: Markets Flat as President Trump Reveals Comey Tapes Don't Exist
By Garrett Baldwin, Economist, Money Morning •
In Dow Jones news today, stock prices were flat as oil prices remain extremely volatile. President Donald Trump also said today that he didn't have a tape of his conversations with former FBI Director James Comey. Read more » -
biotechnology Top Pharmaceutical Stocks to Watch in May 2017
By Alex McGuire, Associate Editor, Money Morning • @AlexMcGuire92 •
The pharma sector has widely outperformed the broader market lately. That's why we've made this list of the 10 top pharmaceutical stocks to watch in May 2017. Read more » -
Stocks If You Own Just One Pharma Stock, Make It This
By Michael A. Robinson, Defense + Tech Specialist, Money Morning • @Robinson_STI •
As I've said before, buying a drugmaker with true billion-dollar "blockbuster" potential is like grabbing a license to print money. Of course, it's always at least possible to grab these shares on their way up, but that's a little like … Read more » -
Stocks This Company Proves the "Ten-Bagger Stock" Is No Myth
By William Patalon III, Executive Editor, Money Morning • @privatebrief •
Back in August 2011, for the very first edition of Private Briefing, I recommended a Belgian biotech firm that I said was "like buying an independent drug development lab" for less than nine bucks a share - $8.60, in fact. I zeroed in on the … Read more »